Opioid withdrawal symptoms after neurolytic splanchnic nerve block in cancer patients.

Ryota YanaizumiYusuke NagamineShinsuke HaradaTomoko KuramochiShuhei OtaTakahisa Goto

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)

OW was observed in 20.8% of the patients in the study. A longer pain and opioid use duration and a larger opioid tapering dose may predispose patients to OW.

Keyphrases

end stage renal disease
chronic pain
chronic kidney disease
newly diagnosed
ejection fraction
pain management
peritoneal dialysis
physical activity
patient reported